Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation
Open Access
- 13 December 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Psychiatry
- Vol. 1 (12), e58
- https://doi.org/10.1038/tp.2011.56
Abstract
Currently used antidepressants elevate monoamine levels in the synaptic cleft. There is good reason to assume that this is not the only source for antidepressant therapeutic activities and that secondary downstream effects may be relevant for alleviating symptoms of depression. We attempted to elucidate affected biochemical pathways downstream of monoamine reuptake inhibition by interrogating metabolomic profiles in DBA/2Ola mice after chronic paroxetine treatment. Metabolomic changes were investigated using gas chromatography-mass spectrometry profiling and group differences were analyzed by univariate and multivariate statistics. Pathways affected by antidepressant treatment were related to energy metabolism, amino acid metabolism and hormone signaling. The identified pathways reveal further antidepressant therapeutic action and represent targets for drug development efforts. A comparison of the central nervous system with blood plasma metabolite alterations identified GABA, galactose-6-phosphate and leucine as biomarker candidates for assessment of antidepressant treatment effects in the periphery.Keywords
This publication has 61 references indexed in Scilit:
- Urinary metabonomics study of anti-depressive effect of Chaihu-Shu-Gan-San on an experimental model of depression induced by chronic variable stress in ratsJournal of Pharmaceutical and Biomedical Analysis, 2011
- Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics-Informed PharmacogenomicsClinical Pharmacology & Therapeutics, 2010
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA AntagonistsScience, 2010
- mTOR signaling: At the crossroads of plasticity, memory and diseaseTrends in Neurosciences, 2010
- The CRF system, stress, depression and anxiety—insights from human genetic studiesMolecular Psychiatry, 2009
- MetaboAnalyst: a web server for metabolomic data analysis and interpretationNucleic Acids Research, 2009
- Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System DiseasesNeuropsychopharmacology, 2008
- Affective disorders, antidepressant drugs and brain metabolismMolecular Psychiatry, 2003
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001
- G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALSAnnual Review of Biochemistry, 1987